Companies: 10,795·Total market cap: $144.5T
Biomind Labs Inc.

Biomind Labs Inc.

BMNDFOTCHealthcare● Active
$0.12
+$0.00(+0.00%)
Market Cap$9308613
P/E Ratio
52W High$0.7
52W Low$0.011
Overview

Biomind Labs Inc. (BMNDF) Revenue

Annual & quarterly revenue history · segment & region breakdown

BMNDF · revenue · updated Jun 9, 2026

Core revenue metrics

Biomind Labs Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.

TTM revenue
$0.00B
4-quarter sum · USD
YoY growth
+0.00%
vs FY
Price / sales
mktCap ÷ TTM rev
Revenue per day
Est. TTM ÷ 365
Revenue / employee
$0K
5 employees
FY
FY
5Y CAGR
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · Biomind Labs Inc. SEC filings · GAAPUpdated: 2026-06-09

Revenue trend

· Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
BMNDF revenue by year · BMNDF revenue history · BMNDF annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income Biomind Labs Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

Biomind Labs Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from Biomind Labs Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

BMNDF revenue · 4 questions

BMNDF's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.

BMNDF revenueBMNDF annual revenuewhat is BMNDF revenueBMNDF TTM revenue

Source: FMP · Biomind Labs Inc. SEC filings · GAAP · Biomind Labs Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026